NIFTY MIDSML HLTH Index PE Ratio
The NIFTY MIDSML HLTH P/E ratio is 59.26 on a market cap weighted basis, derived from the price-to-earnings data of 29 of 30 index constituents with valid EPS. Of these, 1 stocks trade at a low P/E ratio below 15, 2 at moderate valuations between 15 and 25, 12 at elevated earnings multiples between 25 and 50, and 14 at very high valuations above 50. For live index level, EPS data and the full index overview, see NIFTY MIDSML HLTH index composition. Use the NIFTY MIDSML HLTH PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 30 constituents.
NIFTY MIDSML HLTH PE Ratio Distribution — Low, Moderate, High & Very High
1 low (<15), 2 moderate (15–25), 12 high (25–50), 14 very high (50+) among 30 NIFTY MIDSML HLTH stocks. Also explore NIFTY MIDSML HLTH historical trends to track long-term index price performance.
NIFTY MIDSML HLTH PE Ratio Historical Trend — 6 Years
Market cap weighted P/E of NIFTY MIDSML HLTH over 6 years — 29 stocks with valid EPS, current P/E 59.26. Analyse NIFTY MIDSML HLTH constituent earnings to understand aggregate earnings trends across constituents.
NIFTY MIDSML HLTH Component Stocks — P/E Ratio & EPS
29 of 30 NIFTY MIDSML HLTH constituents with valid P/E — sorted by market cap weight.
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
LUPIN
Lupin
|
Healthcare | ₹1.0 Lakh Cr | ₹116.75 | 18.2 |
|
MAXHEALTH
Max Healthcare Institute
|
Healthcare … | ₹98.7K Cr | ₹14.83 | 67.1 |
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹98.4K Cr | ₹16.47 | 89.2 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹98.3K Cr | ₹46.35 | 47.9 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹93.8K Cr | ₹60.34 | 26.0 |
|
FORTIS
Fortis Healthcare
|
Healthcare … | ₹68.6K Cr | ₹13.80 | 65.9 |
|
BIOCON
Biocon
|
Healthcare | ₹66.8K Cr | ₹2.82 | 162.1 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹65.7K Cr | ₹48.26 | 36.7 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹65.4K Cr | ₹192.51 | 29.2 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹55.7K Cr | ₹730.36 | 34.3 |
|
GLAXO
GlaxoSmithKline Pharmaceuticals
|
Healthcare | ₹49.2K Cr | ₹61.15 | 47.6 |
|
GLAND
Gland Pharma
|
Healthcare | ₹47.2K Cr | ₹62.35 | 42.5 |
|
AJANTPHARM
Ajanta Pharma
|
Healthcare | ₹46.5K Cr | ₹84.53 | 40.5 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹44.0K Cr | ₹44.98 | 32.0 |
|
ASTERDM
Aster DM Healthcare
|
Healthcare … | ₹42.1K Cr | ₹7.53 | 166.2 |
|
JBCHEPHARM
J B Chemicals and Pharmaceuticals
|
Healthcare | ₹40.2K Cr | ₹45.16 | 56.3 |
|
MEDANTA
Global Health
|
Healthcare … | ₹38.8K Cr | ₹20.71 | 68.8 |
|
NH
Narayana Hrudayalaya
|
Healthcare … | ₹37.0K Cr | ₹39.67 | 45.7 |
|
KIMS
Krishna Institute of Medical Scien…
|
Healthcare … | ₹33.8K Cr | ₹6.03 | 172.9 |
|
LALPATHLAB
Dr. Lal Path Labs
|
Healthcare … | ₹31.7K Cr | ₹30.24 | 57.5 |
|
NEULANDLAB
Neuland Laboratories
|
Healthcare | ₹29.9K Cr | ₹283.71 | 60.1 |
|
PPLPHARMA
Piramal Pharma
|
Healthcare | ₹28.0K Cr | - | N/A |
|
PFIZER
Pfizer
|
Healthcare | ₹22.8K Cr | ₹157.92 | 30.6 |
|
GRANULES
Granules
|
Healthcare | ₹21.3K Cr | ₹24.47 | 32.1 |
|
POLYMED
Poly Medicure
|
Healthcare | ₹17.6K Cr | ₹31.79 | 57.9 |
|
COHANCE
Cohance Lifesciences
|
Healthcare | ₹17.4K Cr | ₹4.69 | 290.7 |
|
SYNGENE
Syngene International
|
Healthcare | ₹16.4K Cr | ₹7.87 | 73.7 |
|
APLLTD
Alembic Pharmaceuticals
|
Healthcare | ₹16.2K Cr | ₹34.33 | 23.7 |
|
NATCOPHARM
Natco Pharma
|
Healthcare | ₹15.7K Cr | ₹79.20 | 11.4 |
|
RAINBOW
Rainbow Childrens Medicare
|
Healthcare … | ₹14.8K Cr | ₹27.41 | 51.6 |
Track NIFTY MIDSML HLTH PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY MIDSML HLTH Trade to Journal